Product Images Vilazodone Hydrochloride
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 7 images provide visual information about the product associated with Vilazodone Hydrochloride NDC 62332-233 by Alembic Pharmaceuticals Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
vilazodone-10mg-30s.jpg - vilazodone 10mg 30s
This is a medication label for a batch of Trazodone Hydrochloride tablets. The NDC number, dosage, and storage instructions are provided. It also indicates that the medication should be dispensed with a medication guide for each patient and manufactured by Alembic Pharmaceuticals.*
vilazodone-20mg-30s.jpg - vilazodone 20mg 30s
This appears to be a description of a medication called Vilazodone Hydrochloride in tablet form. The tablets are stored at a temperature range of 15-30°C (58-86°F) and each tablet contains 23.3-30 mg of the medication. The manufacturer is Alembic Pharmaceuticals Limited and the medication is dispensed by a pharmacist with a prescription. The text also includes instructions for the manufacturer and a modification guide for each patient.*
vilazodone-40mg-30s.jpg - vilazodone 40mg 30s
Description not-available*
vilazodone-fig.jpg - vilazodone fig
Figure 3 - vilazodone fig3
This text provides population descriptions and fold change values for different subgroups in terms of age, gender, and renal/hepatic impairment. The fold change values represent the changes relative to the reference group (younger subjects, male subjects, and subjects with normal renal and hepatic function). The text also includes information on the confidence intervals for each subgroup.*
Figure 2 - vilazodone figr2
The text describes the impact of Vilazodone on the pharmacokinetics of various drugs and substrates, including CYP3A4, CYP1A2, CYP2A6, CYP2A9, CYP2A19, and P-gp. The data presented include fold changes and 90% confidence intervals for changes in PK and relative changes in AUC, urinary recovery, and plasma concentration for each substrate. The text is a figure caption presenting a chart of this data.*
vilazodone-figur1.jpg - vilazodone figur1
The text is describing a figure depicting the effect of different drugs on the pharmacokinetics of Vilazodone. The drugs include Ethanol, CYP3A4 inhibitors (Ketoconazole), CYP3A4 inducers (Carbamazepine), and Proton Pump inhibitors (Pantoprazole). The figure also shows the change in PK (pharmacokinetics) and AuC (Area under the curve) with respect to a reference. There is also a fold change and a 90% confidence level provided in the figure. No further information is available.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.